• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Med Rev (Berl) . Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic

tetano

Editor, Senior Moderator
Med Rev (Berl)


. 2022 Feb 24;2(1):66-88.
doi: 10.1515/mr-2021-0034. eCollection 2022 Feb 1.
Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic


Yutong Wang[SUP] 1 [/SUP], Ke Zheng[SUP] 1 [/SUP], Wenjing Gao[SUP] 1 [/SUP], Jun Lv[SUP] 1 2 [/SUP], Canqing Yu[SUP] 1 2 [/SUP], Lan Wang[SUP] 3 [/SUP], Zijun Wang[SUP] 2 [/SUP], Bo Wang[SUP] 4 [/SUP], Chunxiao Liao[SUP] 1 2 [/SUP], Liming Li[SUP] 1 2 [/SUP]



Affiliations

Abstract

With the presence of Coronavirus Disease 2019 (COVID-19) asymptomatic infections detected, their proportion, transmission potential, and other aspects such as immunity and related emerging challenges have attracted people's attention. We have found that based on high-quality research, asymptomatic infections account for at least one-third of the total cases, whereas based on systematic review and meta-analysis, the proportion is about one-fifth. Evaluating the true transmission potential of asymptomatic cases is difficult but critical, since it may affect national policies in response to COVID-19. We have summarized the current evidence and found, compared with symptomatic cases, the transmission capacity of asymptomatic individuals is weaker, even though they have similar viral load and relatively short virus shedding duration. As the outbreak progresses, asymptomatic infections have also been found to develop long COVID-19. In addition, the role of asymptomatic infection in COVID-19 remains to be further revealed as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge. Nevertheless, as asymptomatic infections transmit the SARS-CoV-2 virus silently, they still pose a substantial threat to public health. Therefore, it is essential to conduct screening to obtain more knowledge about the asymptomatic infections and to detect them as soon as possible; meanwhile, management of them is also a key point in the fight against COVID-19 community transmission. The different management of asymptomatic infections in various countries are compared and the experience in China is displayed in detail.

Keywords: asymptomatic; coronavirus disease 2019; pre-symptomatic; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom